The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
Medication adherence, defined as medication-taking behavior that aligns with the agreed-upon treatment protocol, is critical for realizing the benefits of prescription medications. Medication adherence can be assessed using electronic adherence monitoring devices (EAMDs), pill bottles or boxes that contain a computer chip that records the date and time of each opening (or “actuation”). Before researchers can use EAMD data, they must apply a series of decision rules to transform actuation data into adherence data. The purpose of this R package ('oncmap') is to transform EAMD actuations in the form of a raw .csv file, information about the patient, regimen, and non-monitored periods into two daily adherence values – Dose Taken and Correct Dose Taken.
Version: | 0.1.5 |
Depends: | R (≥ 3.60) |
Imports: | readr, methods, readxl, dplyr, hms, lubridate, zoo |
Suggests: | knitr, rmarkdown, testthat (≥ 3.0.0) |
Published: | 2025-01-27 |
DOI: | 10.32614/CRAN.package.oncmap |
Author: | Michal Kouril [aut, cre], Meghan McGrady [aut], Mara Constance [aut], Kevin Hommel [aut] |
Maintainer: | Michal Kouril <Michal.Kouril at cchmc.org> |
License: | MIT + file LICENSE |
NeedsCompilation: | no |
Materials: | README |
CRAN checks: | oncmap results |
Reference manual: | oncmap.pdf |
Vignettes: |
FORMATS (source, R code) |
Package source: | oncmap_0.1.5.tar.gz |
Windows binaries: | r-devel: not available, r-release: oncmap_0.1.5.zip, r-oldrel: oncmap_0.1.5.zip |
macOS binaries: | r-release (arm64): oncmap_0.1.5.tgz, r-oldrel (arm64): not available, r-release (x86_64): not available, r-oldrel (x86_64): not available |
Please use the canonical form https://CRAN.R-project.org/package=oncmap to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.